0
0
0
0
1
2
3
$0
Is Insulet solid or fragile? The Finex Financial Health Scanner reads PODD's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $2.7B |
|---|---|
| Net income | $247.1M |
| Operating margin | 17.5% |
| Net margin | 9.1% |
| Cash and investments | $716.1M |
| Total debt | $949.2M |
| Free cash flow | $113.5M |
| Revenue growth (1 year) | 30.7% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.